Comparison of three reference methods for the measurement of intracellular pH using 31P MRS in healthy volunteers and patients with lymphoma

31P magnetic resonance spectroscopy (31P MRS) can measure intracellular pH (pHi) using the chemical shift difference between pH‐dependent inorganic phosphate (Pi) and a pH‐independent reference peak. This study compared three different frequency reference peaks [phosphocreatine (PCr), α resonance of adenosine triphosphate (αATP) and water (using 1H MRS)] in a cohort of 10 volunteers and eight patients with non‐Hodgkin's lymphoma (NHL). Well‐resolved chemical shift imaging (CSI) spectra were acquired on a 1.5T scanner for muscle, liver and tumour. The pH was calculated for all volunteers and patients using the available methods. The consistency of the resulting pH was evaluated. The direct Pi–PCr method was best for those spectra with a very well‐defined PCr, such as muscle (pH=7.05 ± 0.02). In liver, the Pi–αATP method gave more consistent results (pH=7.30 ± 0.06) than the calibrated water‐based method (pH=7.27 ± 0.11). In NHL nodes, the measured pH using the Pi–αATP method was 7.25 ± 0.12. Given that the measured range includes some biological variation in individual patients, treatment‐related changes of the order of 0.1 pH units should be detectable. © 2013 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.

[1]  Ian R. Lanza,et al.  Measurement of human skeletal muscle oxidative capacity by 31P‐MR spectroscopy: A cross‐validation with in vitro measurements , 2011, Journal of magnetic resonance imaging : JMRI.

[2]  K. Nair,et al.  Measurement of Human Skeletal Muscle Oxidative Capacity by 31 P-MRS : A Cross-Validation with in vitro measurements , 2011 .

[3]  G. Semenza,et al.  Uterine DCs are essential for pregnancy. , 2008, The Journal of clinical investigation.

[4]  M. Schocke,et al.  High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. , 2006, Journal of vascular surgery.

[5]  T. Brown,et al.  Methodological standardization for a multi‐institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies , 2004, NMR in biomedicine.

[6]  D J Collins,et al.  Radio-frequency probe for 1H decoupled 31P MRS of the head and neck region. , 2001, Magnetic resonance imaging.

[7]  B. Barbiroli,et al.  In vivo (31)P-MRS assessment of cytosolic [Mg(2+)] in the human skeletal muscle in different metabolic conditions. , 2000, Magnetic resonance imaging.

[8]  J R Griffiths,et al.  Causes and consequences of tumour acidity and implications for treatment. , 2000, Molecular medicine today.

[9]  T. Brown,et al.  Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity , 1998, Magnetic resonance in medicine.

[10]  Michael Molls,et al.  Blood perfusion and microenvironment of human tumors : implications for clinical radiooncology , 1998 .

[11]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[12]  T. Mosher,et al.  Simultaneous determination of intracellular magnesium and pH from the three 31P NMR Chemical shifts of ATP. , 1993, Analytical biochemistry.

[13]  Tumour pH , 1992, The Lancet.

[14]  R. Gillies,et al.  Role of Intracellular pH in Mammalian Cell Proliferation , 1992 .

[15]  D J Collins,et al.  The water resonance as an alternative pH reference: Relevance to in Vivo 31P NMR localized spectroscopy studies , 1991, Magnetic resonance in medicine.

[16]  R. Edwards,et al.  The assessment of treatment response in non-Hodgkin's lymphoma by image guided 31P magnetic resonance spectroscopy. , 1990, British Journal of Cancer.

[17]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[18]  C. Tanaka,et al.  Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy. , 1985, Cancer research.

[19]  P. Matthews,et al.  metabolic recovery after exercise and the assessment of mitochondrial function in Vivo in human skeletal muscle by means of 31P NMR , 1984, Magnetic resonance in medicine.

[20]  D. Gadian,et al.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. , 1983, Molecular biology & medicine.

[21]  G K Radda,et al.  Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. , 1981, The New England journal of medicine.

[22]  J R Griffiths,et al.  31P-NMR investigation of solid tumours in the living rat , 1981, Bioscience reports.

[23]  D. Gadian,et al.  HUMAN-MUSCLE ANALYZED BY P-31 NUCLEAR MAGNETIC-RESONANCE IN INTACT SUBJECTS , 1981 .

[24]  R. B. Moon,et al.  Determination of intracellular pH by 31P magnetic resonance. , 1973, The Journal of biological chemistry.